Tektonyx Bio | Protein Therapeutics from an Expanded Genetic Alphabet

top of page

Contact

Careers

Who we are

Tektonyx is a biotech company focused on developing novel protein therapeutics by harnessing the revolutionary power of a semi-synthetic organism with an expanded genetic alphabet and code.

Foundational Technology

Check out a selection of publications providing background on the development of the expanded genetic alphabet and code and its application to the development of protein therapeutics.

Romesberg, F. E. Creation, Optimization, and Use of Semi-Synthetic Organisms that Store and Retrieve Increased Genetic Information. J Mol Biol 167331 (2021)

Manandhar, M., Chun, E. & Romesberg, F. E. Genetic Code Expansion: Inception, Development, Commercialization. J Am Chem Soc 143, 4859–4878 (2021)

Zhang, Y. et al. A semi-synthetic organism that stores and retrieves increased genetic information. Nature 551, 644–647 (2017)

Malyshev, D. A. & Romesberg, F. E. The Expanded Genetic Alphabet. Angewandte Chemie Int Ed 54, 11930–11944 (2015)

Join Us

We offer an exciting and collaborative environment that fosters innovation and career development.

Open Positions

Scientist/Sr Scientist - Analytics

Reach out to us via email to learn more.

We are excited to hear from you!

info@tektonyxbio.com

bottom of page